Compare CUBI & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CUBI | AMPH |
|---|---|---|
| Founded | 1994 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 885.4M |
| IPO Year | 2010 | 2005 |
| Metric | CUBI | AMPH |
|---|---|---|
| Price | $78.76 | $23.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $85.00 | $28.38 |
| AVG Volume (30 Days) | 201.3K | ★ 326.4K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.99 | N/A |
| EPS | ★ 4.02 | 0.81 |
| Revenue | N/A | ★ $719,887,000.00 |
| Revenue This Year | $24.95 | $6.90 |
| Revenue Next Year | $9.50 | $4.64 |
| P/E Ratio | ★ $19.44 | $28.44 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $59.34 | $16.65 |
| 52 Week High | $84.38 | $29.52 |
| Indicator | CUBI | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 48.07 | 66.77 |
| Support Level | $74.77 | $18.36 |
| Resistance Level | $79.38 | $24.35 |
| Average True Range (ATR) | 1.72 | 0.69 |
| MACD | -0.10 | 0.06 |
| Stochastic Oscillator | 55.39 | 81.95 |
Customers Bancorp Inc is a bank holding company conducting banking activities through its wholly owned subsidiary, Customers Bank. The Bank provides commercial and consumer customers the stability of a regulated financial institution supported by risk management. It serves commercial and corporate businesses nationwide, including healthcare, real estate, specialty finance, fund finance, technology and venture capital banking, mortgage finance and commercial equipment financing, and provides payments and treasury services. The Bank also serves consumers through its branch network, offering residential mortgages and personal loan and deposit products, including Banking-as-a-Service, with services delivered predominantly in Southeastern and Central Pennsylvania, New York, and other states.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.